Redon Christophe E, Schmal Zoe, Tewary Gargi, Mangelinck Adèle, Courbeyrette Régis, Thuret Jean-Yves, Aladjem Mirit I, Bonner William M, Rübe Claudia E, Mann Carl
Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
Department of Radiation Oncology, Saarland University Hospital, 66421 Homburg/Saar, Germany.
Genes (Basel). 2021 Oct 22;12(11):1665. doi: 10.3390/genes12111665.
H2A.J is a poorly studied mammalian-specific variant of histone H2A. We used immunohistochemistry to study its localization in various human and mouse tissues. H2A.J showed cell-type specific expression with a striking enrichment in luminal epithelial cells of multiple glands including those of breast, prostate, pancreas, thyroid, stomach, and salivary glands. H2A.J was also highly expressed in many carcinoma cell lines and in particular, those derived from luminal breast and prostate cancer. H2A.J thus appears to be a novel marker for luminal epithelial cancers. Knocking-out the gene in T47D luminal breast cancer cells reduced the expression of several estrogen-responsive genes which may explain its putative tumorigenic role in luminal-B breast cancer.
H2A.J是一种研究较少的组蛋白H2A的哺乳动物特异性变体。我们使用免疫组织化学研究其在各种人类和小鼠组织中的定位。H2A.J表现出细胞类型特异性表达,在包括乳腺、前列腺、胰腺、甲状腺、胃和唾液腺在内的多个腺体的腔上皮细胞中显著富集。H2A.J在许多癌细胞系中也高度表达,特别是那些源自乳腺腔面癌和前列腺癌的细胞系。因此,H2A.J似乎是腔上皮癌的一种新型标志物。在T47D乳腺腔面癌细胞中敲除该基因会降低几种雌激素反应基因的表达,这可能解释了它在腔面B型乳腺癌中假定的致瘤作用。